Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Egypt / NCT03949049
Recruiting Phase 3

Citicoline as Neuroprotector in Neonates Exposed to Hypoxia

NCT03949049 · tracked via the Priya Life Science Egypt tracker
Sponsor
Sherief Abd-Elsalam
Phase
Phase 3
Started
2019-02-01
Last updated
2019-05-29

Condition(s) studied

Neonatal Hypoxia

Investigational drug(s) / intervention(s)

Citicoline →Placebo

Citicoline: Citacoline as neuroprotector

Placebo: placebo group

Study summary

Citicoline as neuroprotector in neonates exposed to hypoxia: A randomized controlled trial

Eligibility

Sex
ALL
Min age
—
Max age
1 Month
Healthy volunteers
No
Inclusion Criteria: * neonates with hypoxia. Exclusion Criteria: * hypoxic ischemic encephalopathy

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Sherief Abd-Elsalam Cairo Egypt Recruiting

More Sherief Abd-Elsalam trials in Egypt

Pantoprazole in Cisplatin Nephrotoxicity Recruiting
Clinical Study Evaluating Beta Blockers Use and Fracture Risk in Patients With Primary Osteoporosis Recruiting
Docosahexaenoic Acid on Breath Holding Spells in Children Recruiting
Effect of Some Drugs on Rheumatoid Arithritis Activity Recruiting
Effect of Some Drugs on Liver Fibrosis Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03949049 on ClinicalTrials.gov ↗ ← All trials in Egypt